The efficacy and toxicities of combined lobaplatin with paclitaxel as a first-line chemotherapy for advanced esophageal squamous cell carcinoma

BACKGROUND: To assess the efficacy and toxicities of combined lobaplatin with paclitaxel (LP) as a first line chemotherapy in esophageal cancer. METHODS: The clinical data of 45 patients with esophageal squamous cell carcinoma treated initially with lobaplatin-paclitaxel chemotherapy were collected...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Thorac Dis
Main Authors: Chen, Ming-Qiu, Chen, Cheng, Lu, Hai-Jie, Xu, Ben-Hua
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2015
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4635260/
https://ncbi.nlm.nih.gov/pubmed/26623097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.10.23
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki